Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 69
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in United States (Lenalidomide, Daratumumab/rHuPH20)

Recruiting
  • Multiple Myeloma
  • Anchorage, Alaska
  • +698 more
Jan 24, 2023

Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Birmingham, Alabama
  • +60 more
Jan 24, 2023

Collection of Tissue Samples for Cancer Research

Recruiting
  • Neoplasms
  • +3 more
  • Biopsy
  • Atlanta, Georgia
  • +9 more
Jan 23, 2023

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +26 more
Jan 17, 2023

Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Duarte, California
  • +21 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +8 more
  • Birmingham, Alabama
  • +59 more
Dec 13, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Birmingham, Alabama
  • +25 more
Dec 9, 2022

Multiple Myeloma Trial in Worldwide (Pomalidomide, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Mobile, Alabama
  • +278 more
Dec 6, 2022

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +125 more
Nov 21, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))

Active, not recruiting
  • Multiple Myeloma
  • Elranatamab (PF-06863135)
  • Beverly Hills, California
  • +75 more
Oct 4, 2022

Multiple Myeloma Trial in Worldwide (REGN5458)

Recruiting
  • Multiple Myeloma
  • Miami, Florida
  • +26 more
Aug 16, 2022

Multiple Myeloma Trial in United States (Carfilzomib, Pomalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Atlanta, Georgia
  • +8 more
Jul 28, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin frozen liquid, Belantamab mafodotin lyophilized powder)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
Jul 27, 2022

Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))

Completed
Has Results
  • Lymphoma
  • Multiple Myeloma
  • Muscle Shoals, Alabama
  • +215 more
May 5, 2022

Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)

Active, not recruiting
  • Multiple Myeloma
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +8 more
May 24, 2022

Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

Recruiting
  • Pancreatic Cancer
  • +49 more
    • Colorado Springs, Colorado
    • +80 more
    Feb 22, 2022

    Presentation, Treatment Patterns, and Outcomes in Multiple

    Completed
    • Multiple Myeloma
    • No Intervention
    • Little Rock, Arkansas
    • +136 more
    Feb 15, 2022

    Role of Osteocytes in Myeloma Bone Disease

    Recruiting
    • Multiple Myeloma
      • Indianapolis, Indiana
      • +1 more
      Feb 8, 2022

      Multiple Myeloma Trial in Worldwide (Elotuzumab, Dexamethasone, Lenalidomide)

      Active, not recruiting
      • Multiple Myeloma
      • Tucson, Arizona
      • +37 more
      Jan 14, 2022

      Multiple Myeloma Trial in Indianapolis (Lenalidomide Pill, Dexamethasone, Daratumumab)

      Recruiting
      • Multiple Myeloma
      • Lenalidomide Pill
      • +2 more
      • Indianapolis, Indiana
        VA Roudebush Medical Center
      Jan 27, 2022

      Multiple Myeloma Trial in Worldwide (Elotuzumab, Pomalidomide, Dexamethasone)

      Completed
      Has Results
      • Multiple Myeloma
      • Atlanta, Georgia
      • +54 more
      Jan 11, 2022

      Oral Mucositis in Patient's Undergoing Melphalan Conditioning

      Withdrawn
      • Mucositis
      • +3 more
      • Melphalan kinetic study
      • +2 more
      • Indianapolis, Indiana
      • +1 more
      Jan 6, 2022

      Multiple Myeloma Trial in United States (procedure, drug, behavioral)

      Completed
      Has Results
      • Multiple Myeloma
      • One Autologous Transplant
      • +5 more
      • Birmingham, Alabama
      • +35 more
      Oct 19, 2021

      Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

      Active, not recruiting
      • Multiple Myeloma
      • Tucson, Arizona
      • +32 more
      Oct 8, 2021

      Subjects Treated With ACTR T Cell Product

      Terminated
      • B Cell Lymphomas
      • +3 more
      • ACTR T Cell Product
      • Gilbert, Arizona
      • +15 more
      Oct 4, 2021